Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Biochemical and Biophysical Research Communications|February 24, 1997
In vivo transfer efficiency of antisense oligonucleotides into the myocardium using HVJ-liposome methodM Aoki, R Morishita, J Higaki, et al.
Hypertension (Dallas, Tex. : 1979)|December 24, 1997
Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive ratsN Nakano, A Moriguchi, R Morishita, et al.
Gene Therapy|October 1, 1996
In vivo transfer of gene and oligodeoxynucleotides into skin of fetal rats by incubation in amniotic fluidS I Hayashi, R Morishita, M Aoki, et al.
Gene Therapy|March 1, 2000
Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, etsM Aoki, R Morishita, Y Taniyama, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 1, 1989
[Essential thrombocythemia with Philadelphia chromosome]Y Yoshimura, A Nakayama, J Oguchi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2000
In vivo evidence of the importance of cardiac angiotensin-converting enzyme in the pathogenesis of cardiac hypertrophyJ Higaki, M Aoki, R Morishita, et al.
Biochemical and Biophysical Research Communications|October 13, 1995
Expression of local hepatocyte growth factor system in vascular tissuesY Nakamura, R Morishita, J Higaki, et al.
Circulation|November 3, 1998
Novel therapeutic strategy for atherosclerosis: ribozyme oligonucleotides against apolipoprotein(a) selectively inhibit apolipoprotein(a) but not plasminogen gene expressionR Morishita, S Yamada, K Yamamoto, et al.
Gene Therapy|February 1, 1997
Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the beta-galactosidase gene in the noninfarcted area, but not the myocardial infarcted areaM Aoki, R Morishita, J Higaki, et al.
Diabetes|January 1, 1997
Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetesR Morishita, S Nakamura, Y Nakamura, et al.
Pageof 3